View ValuationThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsAlleghany 将来の成長Future 基準チェック /36主要情報n/a収益成長率n/aEPS成長率Insurance 収益成長2.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジLow最終更新日n/a今後の成長に関する最新情報Price Target Changed • May 07Price target increased to US$833Up from US$775, the current price target is provided by 1 analyst. New target price is 14% above last closing price of US$730. Stock is up 38% over the past year.すべての更新を表示Recent updatesReported Earnings • Aug 05Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2022 results: US$12.75 loss per share (down from US$29.00 profit in 2Q 2021). Revenue: US$2.60b (down 11% from 2Q 2021). Net loss: US$171.6m (down 143% from profit in 2Q 2021). Revenue exceeded analyst estimates by 9.9%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is expected to shrink by 19% compared to a 1.1% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 06First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2022 results: EPS: US$9.29 (down from US$16.44 in 1Q 2021). Revenue: US$2.72b (up 2.5% from 1Q 2021). Net income: US$125.7m (down 45% from 1Q 2021). Profit margin: 4.6% (down from 8.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 23%. Earnings per share (EPS) missed analyst estimates by 39%. Over the next year, revenue is forecast to decline by 22% while the industry in the US is not expected to grow. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.Seeking Alpha • Mar 28Merger Arbitrage Mondays: Berkshire Hathaway Acquires Insurer Alleghany For $11.6 BillionBerkshire Hathaway to acquire all outstanding Alleghany shares for $848.02 per share in cash, for a total equity value of approximately $11.6 billion. This is one of the five largest acquisitions in Berkshire's history and it ends Buffett's six-year drought of large acquisitions. KKR and Global Infrastructure Partners complete the acquisition of CyrusOne.Recent Insider Transactions Derivative • Mar 24Independent Director exercised options to buy US$189k worth of stock.On the 22nd of March, John Foos exercised options to buy 223 shares at a strike price of around US$327, costing a total of US$73k. This transaction amounted to 6.0% of their direct individual holding at the time of the trade. Since June 2021, John has owned 3.71k shares directly. Company insiders have collectively bought US$3.8m more than they sold, via options and on-market transactions, in the last 12 months.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improved over the past weekAfter last week's 30% share price gain to US$845, the stock trades at a trailing P/E ratio of 11x. Average forward P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 42% over the past three years.Seeking Alpha • Mar 09Alleghany Corporation: Valuation Is In The Right ZoneWe stayed out of Alleghany Corporation last time we wrote about it. Key drivers were an attractive valuation offset by better choices available elsewhere in the space. The stock has dropped since then, and we take a look at where we stand today.Recent Insider Transactions • Mar 03Senior VP recently sold US$195k worth of stockOn the 28th of February, Christopher Dalrymple sold around 293 shares on-market at roughly US$666 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$3.9m more than they sold in the last 12 months.Reported Earnings • Feb 26Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: US$74.70 (up from US$7.14 in FY 2020). Revenue: US$12.0b (up 35% from FY 2020). Net income: US$1.03b (up US$933.1m from FY 2020). Profit margin: 8.6% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Combined ratio: 97.2% (down from 102.1% in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.Recent Insider Transactions Derivative • Jan 30Senior VP exercised options and sold US$396k worth of stockOn the 26th of January, Christopher Dalrymple exercised options to acquire 611 shares at no cost and sold these for an average price of US$649 per share. This trade did not impact their existing holding. Since March 2021, Christopher's direct individual holding has decreased from 6.00k shares to 4.00k. Company insiders have collectively bought US$3.5m more than they sold, via options and on-market transactions, in the last 12 months.Recent Insider Transactions Derivative • Dec 11Independent Director exercised options and sold US$182k worth of stockOn the 8th of December, Ian Chippendale exercised 523 options at a strike price of around US$327 and sold these shares for an average price of US$675 per share. This trade did not impact their existing holding. Since March 2021, Ian's direct individual holding has increased from 2.53k shares to 2.77k. Company insiders have collectively bought US$3.8m more than they sold, via options and on-market transactions, in the last 12 months.Recent Insider Transactions • Dec 05President recently bought US$5.6m worth of stockOn the 2nd of December, Joseph Brandon bought around 9k shares on-market at roughly US$655 per share. This was the largest purchase by an insider in the last 3 months. This was Joseph's only on-market trade for the last 12 months.Recent Insider Transactions Derivative • Nov 30Independent Director exercised options to buy US$186k worth of stock.On the 23rd of November, Raymond L. Wong exercised 523.00 options at around US$327, then sold 243.00 of them at US$703 each and kept the remainder. Since March 2021, Raymond L.'s direct individual holding has increased from 9.05k shares to 9.28k. Company insiders have collectively sold US$1.6m more than they bought, via options and on-market transactions in the last 12 months.Reported Earnings • Nov 08Third quarter 2021 earnings released: US$8.31 loss per share (vs US$8.86 profit in 3Q 2020)The company reported a soft third quarter result with weaker earnings and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: US$2.87b (up 14% from 3Q 2020). Net loss: US$115.0m (down 191% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.Seeking Alpha • Sep 15Alleghany Corporation: An Interesting Play To Sidestep Crazy ValuationsForward returns on the S&P 500 appear to be headed well into negative territory as per our estimates. We discuss Alleghany Corporation today, a company that we see handily beating the S&P 500 returns. We look at the recent results and tell you how we came up with our estimates.Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS US$29.00 (vs US$12.40 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$2.93b (up 32% from 2Q 2020). Net income: US$403.7m (up 128% from 2Q 2020). Profit margin: 14% (up from 8.0% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Recent Insider Transactions • May 26Senior VP recently sold US$1.4m worth of stockOn the 25th of May, Christopher Dalrymple sold around 2k shares on-market at roughly US$714 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$1.4m more than they bought in the last 12 months.Price Target Changed • May 07Price target increased to US$833Up from US$775, the current price target is provided by 1 analyst. New target price is 14% above last closing price of US$730. Stock is up 38% over the past year.Reported Earnings • May 07First quarter 2021 earnings released: EPS US$16.44 (vs US$25.19 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$2.65b (up 79% from 1Q 2020). Net income: US$230.0m (up US$591.3m from 1Q 2020). Profit margin: 8.7% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Executive Departure • Apr 25President, CEO & Director Weston Hicks has left the companyOn the 23rd of April, Weston Hicks' tenure as President, CEO & Director of the company ended after 16.3 years in the role. As of December 2020, Weston personally held 65.70k shares (US$40m worth at the time). Weston is the only executive to leave the company over the last 12 months. Under Weston's leadership, the company delivered a total shareholder return of 183%.Recent Insider Transactions Derivative • Mar 23Independent Director exercised options and sold US$85k worth of stockOn the 17th of March, Raymond L. Wong exercised 523.00 options at around US$315, then sold 253 of the shares acquired at an average of US$651 per share and kept the remainder. Since June 2020, Raymond L.'s direct individual holding has increased from 8.39k shares to 8.78k. Company insiders have collectively sold US$62k more than they bought, via options and on-market transactions in the last 12 months.Is New 90 Day High Low • Feb 25New 90-day high: US$652The company is up 9.0% from its price of US$598 on 25 November 2020. The American market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Insurance industry, which is also up 9.0% over the same period.Reported Earnings • Feb 25Full year 2020 earnings released: EPS US$7.14 (vs US$59.44 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$8.90b (down 1.6% from FY 2019). Net income: US$101.8m (down 88% from FY 2019). Profit margin: 1.1% (down from 9.5% in FY 2019). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Recent Insider Transactions Derivative • Jan 21Senior VP exercised options and sold US$123k worth of stockOn the 17th of January, Christopher Dalrymple exercised options to acquire 202.00 shares at no cost and sold these for an average price of US$609 per share. This trade did not impact their existing holding. Since March 2020, Christopher has owned 5.51k shares directly. Company insiders have collectively sold US$25k more than they bought, via options and on-market transactions in the last 12 months.Is New 90 Day High Low • Nov 10New 90-day high: US$625The company is up 14% from its price of US$550 on 12 August 2020. The American market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 5.0% over the same period.Reported Earnings • Nov 05Third quarter 2020 earnings released: EPS US$8.86The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$2.52b (up 17% from 3Q 2019). Net income: US$126.5m (up 40% from 3Q 2019). Profit margin: 5.0% (up from 4.2% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Is New 90 Day High Low • Oct 21New 90-day high: US$573The company is up 8.0% from its price of US$533 on 23 July 2020. The American market is also up 8.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Insurance industry, which is down 2.0% over the same period.業績と収益の成長予測NYSE:Y - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数6/30/202211,7373552,0082,073N/A3/31/202212,0699311,8671,929N/A12/31/202112,0041,0351,8011,860N/A9/30/202111,1136781,7721,827N/A6/30/202110,7699191,6141,667N/A3/31/202110,0686931,4451,486N/A12/31/20208,8971029991,037N/A9/30/20208,534-261,0301,070N/A6/30/20208,171-62809850N/A3/31/20208,20256730774N/A12/31/20199,041858667714N/A9/30/20197,967114487507N/A6/30/20197,984309393427N/A3/31/20197,623308316341N/A12/31/20186,88740379402N/A9/30/20187,331905305343N/A6/30/20186,821306378391N/A3/31/20186,477113477483N/A12/31/20176,42590446446N/A9/30/20176,2096640645N/A6/30/20176,156476660675N/A3/31/20176,185452684711N/A12/31/20166,131457769793N/A9/30/20166,028541337338N/A6/30/20165,602482296319N/A3/31/20165,321587N/A148N/A12/31/20154,999558N/A326N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: Yの予測収益成長率 (年間0% ) は 貯蓄率 ( 2% ) を上回っています。収益対市場: Yの収益 ( 0% ) はUS市場 ( 16.8% ) よりも速いペースで成長すると予測されています。高成長収益: Yの収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: Yの収益は今後 3 年間で減少すると予想されています (年間0% )。高い収益成長: Yの収益は今後 3 年間で減少すると予測されています (年間0% )。一株当たり利益成長率予想将来の株主資本利益率将来のROE: Yの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YInsurance 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/10/19 08:01終値2022/10/18 00:00収益2022/06/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Alleghany Corporation 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関Lawrence GreenbergBrean Capital Historical (Janney Montgomery)Matthew CarlettiCitizens JMP Securities, LLCPhilip StefanoDeutsche Bank3 その他のアナリストを表示
Price Target Changed • May 07Price target increased to US$833Up from US$775, the current price target is provided by 1 analyst. New target price is 14% above last closing price of US$730. Stock is up 38% over the past year.
Reported Earnings • Aug 05Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2022 results: US$12.75 loss per share (down from US$29.00 profit in 2Q 2021). Revenue: US$2.60b (down 11% from 2Q 2021). Net loss: US$171.6m (down 143% from profit in 2Q 2021). Revenue exceeded analyst estimates by 9.9%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is expected to shrink by 19% compared to a 1.1% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 06First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2022 results: EPS: US$9.29 (down from US$16.44 in 1Q 2021). Revenue: US$2.72b (up 2.5% from 1Q 2021). Net income: US$125.7m (down 45% from 1Q 2021). Profit margin: 4.6% (down from 8.7% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 23%. Earnings per share (EPS) missed analyst estimates by 39%. Over the next year, revenue is forecast to decline by 22% while the industry in the US is not expected to grow. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
Seeking Alpha • Mar 28Merger Arbitrage Mondays: Berkshire Hathaway Acquires Insurer Alleghany For $11.6 BillionBerkshire Hathaway to acquire all outstanding Alleghany shares for $848.02 per share in cash, for a total equity value of approximately $11.6 billion. This is one of the five largest acquisitions in Berkshire's history and it ends Buffett's six-year drought of large acquisitions. KKR and Global Infrastructure Partners complete the acquisition of CyrusOne.
Recent Insider Transactions Derivative • Mar 24Independent Director exercised options to buy US$189k worth of stock.On the 22nd of March, John Foos exercised options to buy 223 shares at a strike price of around US$327, costing a total of US$73k. This transaction amounted to 6.0% of their direct individual holding at the time of the trade. Since June 2021, John has owned 3.71k shares directly. Company insiders have collectively bought US$3.8m more than they sold, via options and on-market transactions, in the last 12 months.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improved over the past weekAfter last week's 30% share price gain to US$845, the stock trades at a trailing P/E ratio of 11x. Average forward P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 42% over the past three years.
Seeking Alpha • Mar 09Alleghany Corporation: Valuation Is In The Right ZoneWe stayed out of Alleghany Corporation last time we wrote about it. Key drivers were an attractive valuation offset by better choices available elsewhere in the space. The stock has dropped since then, and we take a look at where we stand today.
Recent Insider Transactions • Mar 03Senior VP recently sold US$195k worth of stockOn the 28th of February, Christopher Dalrymple sold around 293 shares on-market at roughly US$666 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$3.9m more than they sold in the last 12 months.
Reported Earnings • Feb 26Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: US$74.70 (up from US$7.14 in FY 2020). Revenue: US$12.0b (up 35% from FY 2020). Net income: US$1.03b (up US$933.1m from FY 2020). Profit margin: 8.6% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Combined ratio: 97.2% (down from 102.1% in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
Recent Insider Transactions Derivative • Jan 30Senior VP exercised options and sold US$396k worth of stockOn the 26th of January, Christopher Dalrymple exercised options to acquire 611 shares at no cost and sold these for an average price of US$649 per share. This trade did not impact their existing holding. Since March 2021, Christopher's direct individual holding has decreased from 6.00k shares to 4.00k. Company insiders have collectively bought US$3.5m more than they sold, via options and on-market transactions, in the last 12 months.
Recent Insider Transactions Derivative • Dec 11Independent Director exercised options and sold US$182k worth of stockOn the 8th of December, Ian Chippendale exercised 523 options at a strike price of around US$327 and sold these shares for an average price of US$675 per share. This trade did not impact their existing holding. Since March 2021, Ian's direct individual holding has increased from 2.53k shares to 2.77k. Company insiders have collectively bought US$3.8m more than they sold, via options and on-market transactions, in the last 12 months.
Recent Insider Transactions • Dec 05President recently bought US$5.6m worth of stockOn the 2nd of December, Joseph Brandon bought around 9k shares on-market at roughly US$655 per share. This was the largest purchase by an insider in the last 3 months. This was Joseph's only on-market trade for the last 12 months.
Recent Insider Transactions Derivative • Nov 30Independent Director exercised options to buy US$186k worth of stock.On the 23rd of November, Raymond L. Wong exercised 523.00 options at around US$327, then sold 243.00 of them at US$703 each and kept the remainder. Since March 2021, Raymond L.'s direct individual holding has increased from 9.05k shares to 9.28k. Company insiders have collectively sold US$1.6m more than they bought, via options and on-market transactions in the last 12 months.
Reported Earnings • Nov 08Third quarter 2021 earnings released: US$8.31 loss per share (vs US$8.86 profit in 3Q 2020)The company reported a soft third quarter result with weaker earnings and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: US$2.87b (up 14% from 3Q 2020). Net loss: US$115.0m (down 191% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
Seeking Alpha • Sep 15Alleghany Corporation: An Interesting Play To Sidestep Crazy ValuationsForward returns on the S&P 500 appear to be headed well into negative territory as per our estimates. We discuss Alleghany Corporation today, a company that we see handily beating the S&P 500 returns. We look at the recent results and tell you how we came up with our estimates.
Reported Earnings • Aug 08Second quarter 2021 earnings released: EPS US$29.00 (vs US$12.40 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$2.93b (up 32% from 2Q 2020). Net income: US$403.7m (up 128% from 2Q 2020). Profit margin: 14% (up from 8.0% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Recent Insider Transactions • May 26Senior VP recently sold US$1.4m worth of stockOn the 25th of May, Christopher Dalrymple sold around 2k shares on-market at roughly US$714 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$1.4m more than they bought in the last 12 months.
Price Target Changed • May 07Price target increased to US$833Up from US$775, the current price target is provided by 1 analyst. New target price is 14% above last closing price of US$730. Stock is up 38% over the past year.
Reported Earnings • May 07First quarter 2021 earnings released: EPS US$16.44 (vs US$25.19 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$2.65b (up 79% from 1Q 2020). Net income: US$230.0m (up US$591.3m from 1Q 2020). Profit margin: 8.7% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Executive Departure • Apr 25President, CEO & Director Weston Hicks has left the companyOn the 23rd of April, Weston Hicks' tenure as President, CEO & Director of the company ended after 16.3 years in the role. As of December 2020, Weston personally held 65.70k shares (US$40m worth at the time). Weston is the only executive to leave the company over the last 12 months. Under Weston's leadership, the company delivered a total shareholder return of 183%.
Recent Insider Transactions Derivative • Mar 23Independent Director exercised options and sold US$85k worth of stockOn the 17th of March, Raymond L. Wong exercised 523.00 options at around US$315, then sold 253 of the shares acquired at an average of US$651 per share and kept the remainder. Since June 2020, Raymond L.'s direct individual holding has increased from 8.39k shares to 8.78k. Company insiders have collectively sold US$62k more than they bought, via options and on-market transactions in the last 12 months.
Is New 90 Day High Low • Feb 25New 90-day high: US$652The company is up 9.0% from its price of US$598 on 25 November 2020. The American market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Insurance industry, which is also up 9.0% over the same period.
Reported Earnings • Feb 25Full year 2020 earnings released: EPS US$7.14 (vs US$59.44 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$8.90b (down 1.6% from FY 2019). Net income: US$101.8m (down 88% from FY 2019). Profit margin: 1.1% (down from 9.5% in FY 2019). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Recent Insider Transactions Derivative • Jan 21Senior VP exercised options and sold US$123k worth of stockOn the 17th of January, Christopher Dalrymple exercised options to acquire 202.00 shares at no cost and sold these for an average price of US$609 per share. This trade did not impact their existing holding. Since March 2020, Christopher has owned 5.51k shares directly. Company insiders have collectively sold US$25k more than they bought, via options and on-market transactions in the last 12 months.
Is New 90 Day High Low • Nov 10New 90-day high: US$625The company is up 14% from its price of US$550 on 12 August 2020. The American market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 5.0% over the same period.
Reported Earnings • Nov 05Third quarter 2020 earnings released: EPS US$8.86The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$2.52b (up 17% from 3Q 2019). Net income: US$126.5m (up 40% from 3Q 2019). Profit margin: 5.0% (up from 4.2% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Is New 90 Day High Low • Oct 21New 90-day high: US$573The company is up 8.0% from its price of US$533 on 23 July 2020. The American market is also up 8.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Insurance industry, which is down 2.0% over the same period.